Results 151 to 160 of about 79,473 (337)

Patients' Ability to Self‐Manage Their Surgical Wound to Prevent Wound Complications: A Cross‐Sectional Study

open access: yesJournal of Advanced Nursing, EarlyView.
ABSTRACT Aims To provide insights into postdischarge patients' experiences and preferences regarding surgical wound care education at discharge in the Netherlands. Background Patient involvement in wound care practices postdischarge is beneficial for the prevention of surgical site infections and has become an essential component in reducing the burden
Hannah Groenen   +6 more
wiley   +1 more source

A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis. [PDF]

open access: yes, 2013
ObjectiveEtrolizumab (rhuMAb β7, anti-β7, PRO145223) is a humanised monoclonal antibody targeting the β7 subunit of the heterodimeric integrins α4β7 and αEβ7, which are implicated in leucocyte migration and retention in ulcerative colitis (UC).
Baumgart, Daniel C   +16 more
core  

Gastrointestinal Electrical Stimulation as Prevention of Postoperative Ileus—A Blinded Randomized Controlled Porcine Trial

open access: yesNeurogastroenterology &Motility, EarlyView.
In this animal study, direct postoperative electrical stimulation of the sigmoid colon shortened the length of postoperative ileus in an animal model. ABSTRACT Introduction Postoperative ileus (POI) is a condition characterized by a transient cessation of gastrointestinal function caused by surgical trauma and represents a clinical challenge after ...
Anne Kraushaar Martensen   +4 more
wiley   +1 more source

Urogynecologic Symptoms Are Not Specific to Anatomic Region of Digestive Symptoms

open access: yesNeurogastroenterology &Motility, EarlyView.
Urogynecologic symptoms are common in patients with DGBIs, regardless of the affected area of the GI tract. We recommend screening for these symptoms in all patients with chronic GI symptoms. ABSTRACT Background/Aims Many patients with digestive symptoms describe underlying urinary or gynecologic symptoms, which may increase visceral sensitivity in the
Madison Simons   +5 more
wiley   +1 more source

Cancer treatment and survivorship statistics, 2025

open access: yesCA: A Cancer Journal for Clinicians, EarlyView.
Abstract The number of people living with a history of cancer in the United States continues to rise because of the growth and aging of the population as well as improved survival through advances in early detection and treatment. To assist the public health community serve the needs of these survivors, the American Cancer Society and the National ...
Nikita Sandeep Wagle   +9 more
wiley   +1 more source

Swollen limbs and bone pain : a case report [PDF]

open access: yes, 2005
A 50 year old man presented with peripheral oedema, abdominal distension and a pulmonary opacity on CXR. He subsequently perforated his sigmoid colon as a complication of diverticulitis with pericolic abscess. After colectomy his postoperative period was
Cacciottolo, Joseph M.   +2 more
core  

Prognostic factors and long‐term outcomes with endoscopic submucosal dissection for colorectal tumors in patients aged 75 years or older

open access: yesDEN Open, Volume 6, Issue 1, April 2026.
Abstract Background Studies regarding the long‐term outcomes of endoscopic submucosal dissection (ESD) performed in older patients with colorectal tumors are limited. Therefore, in this study, we aimed to analyze the long‐term outcomes of older patients with colorectal tumors who underwent ESD and identify prognostic factors.
Takaya Miura   +16 more
wiley   +1 more source

Antitumor efficacy of intermittent low‐dose erlotinib plus sulindac via MHC upregulation and remodeling of the immune cell niche

open access: yesInternational Journal of Cancer, Volume 157, Issue 2, Page 355-370, 15 July 2025.
What's new? Novel immunomodulatory insights derived from experimental models and clinical samples reveal the cancer‐preventive potential of intermittent low‐dose erlotinib plus sulindac (ERL + SUL). This study shows that ERL + SUL treatment upregulates MHC class I and II expression and remodels the immune cell niche, with significant tumor suppression ...
Chakrapani Tripathi   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy